Yoshiyuki Taoda

Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19

Yuto Unoh, Shota Uehara, Kenji Nakahara et al. · Journal of Medicinal Chemistry · 2022 · 553 citations · Full text

Epigenetic Regulation of Autophagy by the Methyltransferase G9a

Amaia Artal-Martinez de Narvajas, Timothy S. Gomez, Jin‐San Zhang et al. · Molecular and Cellular Biology · 2013 · 214 citations · Full text

Histone Modifications, Mitophagy, Epigenetic Change +16

Carbamoyl Pyridone HIV-1 Integrase Inhibitors 3. A Diastereomeric Approach to Chiral Nonracemic Tricyclic Ring Systems and the Discovery of Dolutegravir (S/GSK1349572) and (S/GSK1265744)

Brian A. Johns, Takashi Kawasuji, Jason G. Weatherhead et al. · Journal of Medicinal Chemistry · 2013 · 181 citations · Full text

Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +15

Boron Cluster-based Development of Potent Nonsecosteroidal Vitamin D Receptor Ligands: Direct Observation of Hydrophobic Interaction between Protein Surface and Carborane

Shinya Fujii, Hiroyuki Masuno, Yoshiyuki Taoda et al. · Journal of the American Chemical Society · 2011 · 115 citations

Carbamoyl Pyridone HIV-1 Integrase Inhibitors. 2. Bi- and Tricyclic Derivatives Result in Superior Antiviral and Pharmacokinetic Profiles

Takashi Kawasuji, Brian A. Johns, Hiroshi Yoshida et al. · Journal of Medicinal Chemistry · 2013 · 89 citations

Antiviral Compound, Medicine, Immunology +14